Although we have demonstrated that the activation of forward signaling is required for the pro-angiogenic effect of EPHA2, this finding is distinct from the results of previous studies on tumor cells, in which Ephrin A1-dependent activation of EPHA2 inhibits the proliferation and migration of cancer cells 49, 50. The gene discussed is EFNA1; the disease is cancer.